Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
Bears may fuss over the routine consolidation combined with rotational action, but here's how I look at the moves.
Do not fear the housing sales boom -- this is good news and I'll tell you why.
Our look at the stocks of both FUBO and PUBM.
I see a good trade down the road in this commercial fleet alternative-power truck name.